Daniel A. Carestio

President and CEO at STERIS

Since July 1, 2021

Age

51 years

Tenure

Joined STE in August 2015 and held various roles including Senior Vice President, Sterilization and Disinfection; Senior Vice President, STERIS Applied Sterilization Technologies (AST) and Life Sciences; and Senior Vice President and Chief Operating Officer before being promoted to President and CEO in July 2021.

Also at STERIS

Andrew Xilas

Senior Vice President and General Manager, Dental

CLM

Cary L. Majors

Senior Vice President and President, Healthcare

JAZ

J. Adam Zangerle

Senior Vice President, General Counsel, and Secretary

About

Daniel A. Carestio, aged 51 as of March 31, 2024 , has exhibited a strong record of leadership at STE. His tenure in the organization reflects a dedication to operational excellence and strategic growth, developed over several progressive roles.

He began his journey with STE in August 2015 as Senior Vice President, STERIS Applied Sterilization Technologies (AST) and Life Sciences, before moving into roles as Senior Vice President, Sterilization and Disinfection and later as Senior Vice President and Chief Operating Officer. His rise within the company highlights his deep understanding of the healthcare and sterilization industries, as well as his ability to manage complex operations.

In July 2021, he was promoted to President and CEO, marking a significant milestone in his career. His leadership has been instrumental in guiding the company through industry challenges and leveraging his extensive experience to enhance its operational capabilities and strategic direction.

$STE Performance Under Daniel A. Carestio

Past Roles

Organization	Role	Date Range
STERIS	Senior Vice President and Chief Operating Officer	August 2018 – July 2021
STERIS	Senior Vice President, Sterilization and Disinfection	February 2018 – July 2018
STERIS	Senior Vice President, STERIS Applied Sterilization Technologies (AST) and Life Sciences	August 2015 – February 2018

Fixed Compensation

Data from FY 2024

Component Name	Amount	Payment Schedule	Additional Details
Base Salary	$1,030,600	Regular salary paid during fiscal 2024	Represents a 6.26% increase from fiscal 2023’s base salary of $969,862
All Other Compensation	$11,987	Paid concurrently with base salary	Primarily includes employer matching contributions to the 401(k) plan, including an employer contribution of $11,957

Performance Compensation

Data from FY 2024

Annual Incentive Compensation (Cash Bonus)

Metric	Detail
Target Bonus Percentage	125.0% of base salary
Base Salary	$1,030,600
Bonus Range	0% to 200% of the target bonus
Performance Metric	Based on financial performance measures (EBIT and Free Cash Flow)
Achievement Level	87.2% aggregate financial achievement
Actual Payout Amount	$1,123,539 at an achievement level of 87.2%
Evaluation Period	Fiscal 2024
Additional Conditions	Committee may modify based on personal objectives; bonus levels are aligned with peer company medians

No vesting schedule applies since this is a cash bonus incentive.